Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  CAE Inc.    CAE   CA1247651088


Delayed Quote. Delayed Toronto Stock Exchange - 02/25 01:31:41 pm
38.48 CAD   -1.61%
02/13CAE : USA achieves AS9100 certification
02/12Companies feel impact of coronavirus outbreak in China
02/11CAE : renews its normal course issuer bid
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

CAE, Inc. : CAE Healthcare sells its 1,000th iStan patient simulator

share with twitter share with LinkedIn share with facebook
share via e-mail
10/31/2012 | 02:06pm EST

Montreal, Canada, October 31, 2012 - (NYSE: CAE; TSX: CAE) - CAE Healthcare announced today that it has sold its 1,000th iStan patient simulator. It was sold to the Paris Simulation Center at the University of Louisville School of Medicine in the United States. Developed in 2007, iStan was the first high-fidelity patient simulator that could be operated wirelessly for added mobility and realism in healthcare training.

Since his introduction to the market, iStan has simulated auto accidents on roadways, logging injuries in forests, heat stroke at the beach, burns from chemical plant explosions and football injuries on the field. He has been transported from point-of-injury to simulated emergency or operating rooms-all while maintaining the clinical signs and symptoms of his simulated condition.

"When he was introduced five years ago, iStan was a technological breakthrough-the first simulator that could blink, bleed, talk, cry, and simulate a real patient in almost any setting," said Michael Bernstein, President of CAE Healthcare. "iStan set a standard in the industry, and he is still one of our best-selling simulators. Today, wireless patient simulation has been widely adopted among emergency medical responders, hospital teams and medical education programs."

"We have a long history using CAE Healthcare -formerly METI- simulators," said Kevin Martin, Operations Director of the Paris Simulation Center. "We are excited about integrating this new technology into curriculum development and scheduling. We recently purchased CAE Healthcare's LearningSpace for center management and are looking to use iStan and our other simulators to deliver training content online."

Established in 2001, the 2,500-square-foot Paris Simulation Center supports training of current and future healthcare professionals at the University of Louisville Health Science Campus. The center works closely with departments, course directors, individual faculty, and other health care organizations to develop education experiences that effectively utilize simulation.

About CAE Healthcare 
CAE Healthcare offers cutting-edge learning tools to healthcare students and professionals, allowing them to develop practical experience through risk-free simulation training before treating real patients. CAE Healthcare's full spectrum of simulation solutions includes surgical and imaging simulation, curriculum, center management and highly realistic adult, pediatric and baby patient simulators. Today, approximately 7,000 CAE Healthcare simulators are in use worldwide by medical schools, nursing schools, hospitals, defense forces and other entities. www.caehealthcare.com

About CAE
CAE is a global leader in modeling, simulation and training for civil aviation and defense. The company employs approximately 8,000 people at more than 100 sites and training locations in approximately 30 countries. CAE offers civil aviation, military, and helicopter training services in more than 45 locations worldwide and trains approximately 100,000 crewmembers yearly. In addition, the CAE Oxford Aviation Academy offers training to aspiring pilot cadets in 11 CAE-operated flight schools. CAE's business is diversified, ranging from the sale of simulation products to providing comprehensive services such as training and aviation services, integrated enterprise solutions, in-service support and crew sourcing. The company applies simulation expertise and operational experience to help customers enhance safety, improve efficiency, maintain readiness and solve challenging problems. CAE is leveraging its simulation capabilities in new markets such as healthcare and mining. www.cae.com


High-resolution photos of CAE Healthcare's iStan patient simulator are available on www.cae.com/photos


Nathalie Bourque, Vice President, Public Affairs and Global Communications, +1-514-734-5788, nathalie.bourque@cae.com

Investor relations: Andrew Arnovitz, Vice President, Investor Relations and Strategy, +1-514-734-5760, andrew.arnovitz@cae.com

Trade media:  Tess Mitchell, Vice President, CAE Healthcare Marketing, +1-941-504-3255, tess.mitchell@cae.com

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CAE INC.
02/13CAE : USA achieves AS9100 certification
02/12Companies feel impact of coronavirus outbreak in China
02/11CAE : renews its normal course issuer bid
02/11CAE : reports third quarter fiscal 2020 results
02/07CAE beats on profit on training demand, inks 737 MAX simulator sales
02/07CAE : reports net income of $99.8 million as revenue climbs in all segments
02/07CAE : reports third quarter fiscal 2020 results
02/07CAE : renews its normal course issuer bid
02/05CAE : supports state-of-the-art healthcare training at the MUHC
02/04CAE INC. : quaterly earnings release
More news
Financials (CAD)
Sales 2020 3 738 M
EBIT 2020 588 M
Net income 2020 367 M
Debt 2020 2 188 M
Yield 2020 1,11%
P/E ratio 2020 28,9x
P/E ratio 2021 24,5x
EV / Sales2020 3,37x
EV / Sales2021 3,03x
Capitalization 10 406 M
Chart CAE INC.
Duration : Period :
CAE Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CAE INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 9
Average target price 42,25  CAD
Last Close Price 39,11  CAD
Spread / Highest target 15,1%
Spread / Average Target 8,03%
Spread / Lowest Target -0,28%
EPS Revisions
Marc Parent President, Chief Executive Officer & Director
John Paul Manley Chairman
Pascal Grenier VP-Global Operations, Technologies & Innovation
Sonya Branco Chief Financial Officer & Vice President-Finance
Michael M. Fortier Independent Director
Sector and Competitors